Recovery, coming soon.
BPC-157 and the Wolverine and Klow blends are some of the most requested peptides for joints, tendons and soft-tissue recovery. They are not available yet, because the FDA has not finished clearing them for pharmacy compounding. Join the list and we will tell you when they are.
Common concerns, worth a real conversation.
Answer a few questions and a licensed clinician will recommend what fits, or tell you if something else is worth checking first.
Coming soon, clearly labeled.
These products are not available yet. Each page explains what it is, and you can join the list for updates.
BPC-157 injection
A subcutaneous peptide injection used to support the body's own healing and anti-inflammatory processes.
BPC-157 capsules
An oral, needle-free capsule form of BPC-157 for systemic tissue-repair and gut-health support.
BPC-157 + TB-500 injection
A combination recovery injection pairing BPC-157 with TB-500 for broader tissue-repair support.
BPC-157 + GHK-Cu + KPV + TB-500 injection
A four-peptide blend combining tissue repair, skin support, and anti-inflammatory action in one injection.
BPC-157 + KPV + TB-500 injection
A three-peptide recovery blend adding targeted anti-inflammatory support to the BPC-157/TB-500 combination.
A licensed clinician decides whether a prescription is right for you; payment does not guarantee one. See every price
an FDA advisory committee recommended BPC-157, TB-500 and KPV for the compounding list
FDA Pharmacy Compounding Advisory Committeefinal FDA action, with no set date
FDA 503A bulk drug substances listSimple, private, and personal.
Join the list
Leave your email on any recovery product.
FDA action
Pharmacies can prepare these peptides only once the FDA clears them.
Clinician review
When available, a licensed clinician reviews your history first.
Delivered
Approved treatments ship discreetly to your door.
Your first months, step by step.
Every body is different, and individual results vary. This is the typical arc your clinician will walk you through.
Not available
We do not sell these peptides yet.
FDA review
The FDA decides whether pharmacies can compound them.
Pages go live
Prices and the Start button appear on each product.
Clearly labeled
Compounded, not FDA-approved, on every product.
One clear price. No membership.
Recovery care is coming soon. When it opens, every price will be published here before you pay.
- Clinician review before anything is prescribed
- Every product labeled compounded, not FDA-approved
- Messaging with your care team
- Discreet delivery
- Prices published before you pay
- An email when products become available
Important safety information
This is not the full list. Your clinician reviews all risks with you, and the full prescribing information comes with your medication. Full safety information
- Not available yet. These peptides are not sold on LovCura until pharmacies are allowed to compound them.
- Compounded peptides are not FDA-approved. Much of the evidence comes from animal and laboratory studies, with limited research in people.
- Injections can cause redness, swelling or bruising where they are given.
The FDA has not finished adding BPC-157 to the list of substances pharmacies may use for compounding. An advisory committee recommended it in July 2026, but the final decision has no set date. We do not sell it until it is allowed.
Blends of recovery peptides. Wolverine pairs BPC-157 with TB-500, Wolverine 2 adds KPV, and Klow adds GHK-Cu and KPV. All are coming soon.
Yes. Labs and a clinician review are available today, and your clinician can talk through what may help in the meantime.
Ready when you are.
Five minutes to start. A licensed clinician reviews your answers and recommends what fits. No commitment.